Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6ZND

[1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitors

Summary for 6ZND
Entry DOI10.2210/pdb6znd/pdb
DescriptorcGMP-dependent 3',5'-cyclic phosphodiesterase, ZINC ION, MAGNESIUM ION, ... (5 entities in total)
Functional Keywordspde2a inhibitor, fep, sbdd, free energy perturbation, molecular dynamics, alzheimers disease, phosphodiesterase, molecular design, binding free energy, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight83839.03
Authors
Tresadern, G.,Leonard, P.M. (deposition date: 2020-07-06, release date: 2020-07-22, Last modification date: 2024-01-31)
Primary citationTresadern, G.,Velter, I.,Trabanco, A.A.,Van den Keybus, F.,Macdonald, G.J.,Somers, M.V.F.,Vanhoof, G.,Leonard, P.M.,Lamers, M.B.A.C.,Van Roosbroeck, Y.E.M.,Buijnsters, P.J.J.A.
[1,2,4]Triazolo[1,5- a ]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided Exploration.
J.Med.Chem., 63:12887-12910, 2020
Cited by
PubMed Abstract: We describe the hit-to-lead exploration of a [1,2,4]triazolo[1,5-]pyrimidine phosphodiesterase 2A (PDE2A) inhibitor arising from high-throughput screening. X-ray crystallography enabled structure-guided design, leading to the identification of preferred substructural components. Further rounds of optimization used relative binding free-energy calculations to prioritize different substituents from the large accessible chemical space. The free-energy perturbation (FEP) calculations were performed for 265 putative PDE2A inhibitors, and 100 compounds were synthesized representing a relatively large prospective application providing unexpectedly active molecules with IC's from 2340 to 0.89 nM. Lead compound originating from the FEP calculations showed PDE2A inhibition IC of 1.3 ± 0.39 nM, ∼100-fold selectivity versus other PDE enzymes, clean cytochrome P450 profile, target occupancy, and promise for further lead optimization.
PubMed: 33105987
DOI: 10.1021/acs.jmedchem.0c01272
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.35 Å)
Structure validation

248942

PDB entries from 2026-02-11

PDB statisticsPDBj update infoContact PDBjnumon